You are currently viewing a new version of our website. To view the old version click .
Vaccines
  • Correction
  • Open Access

11 July 2023

Correction: Goodman et al. Human Papillomavirus Vaccine Impact and Effectiveness in Six High-Risk Populations: A Systematic Literature Review. Vaccines 2022, 10, 1543

,
,
and
1
Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ 07065, USA
2
Global Medical and Scientific Affairs, MSD Sharp and Dohme GmbH, 81673 Munich, Germany
3
OPEN Health, Bethesda, MD 20814, USA
*
Author to whom correspondence should be addressed.
This article belongs to the Collection HPV-Vaccines
The authors wish to make the following corrections to this paper [1]. In the original article, there was a mistake in Figure 2 as published. A few of the references were missed from the legend for Figure 2B,C. The corrected Figure 2 appears below.
Figure 2. 4vHPV vaccine effectiveness in patients with recurrent respiratory papillomatosis. Panel (A) shows the tumor response within an individual patient defined as: CR, complete response; PR, partial response; and RD, recurrent disease. Three studies defined PR as a >50% increase in the interval between surgical procedures [32,49,50]; one study as a >50% increase in the interval between surgical procedures or persistent papillomas that were not growing and did not require surgical interventions for >12 months [34]; one study as any increase in the time to recurrence [41]; and one study as >12 months with no appreciable growth of papillomas [51]. Three studies defined the ‘PR or RD’ category as any recurrence [37–39]. No definitions were provided in the remaining two studies [17,26]. These are descriptive, within person responses, so vaccine effectiveness is not calculated. Panel (B) shows the increase in the mean intersurgical interval. The symbol * indicates statistical significance at p < 0.05. Panel (C) shows the decrease in the mean number of surgeries per month. The symbol * indicates statistical significance at p < 0.05. For all panels, data from the Rosenberg 2019 Danish cohort were collected by the study authors while data from the Romanian cohort were new, never reported data from a prior published study [52].
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Goodman, E.; Reuschenbach, M.; Kaminski, A.; Ronnebaum, S. Human Papillomavirus Vaccine Impact and Effectiveness in Six High-Risk Populations: A Systematic Literature Review. Vaccines 2022, 10, 1543. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.